Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferons: pleiotropic cellular modulators.

E C Borden1

  • 1Cancer Center, Medical College of Wisconsin, Milwaukee 53226.

Clinical Immunology and Immunopathology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.

Oncogene·2012
Same author

G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer.

Oncogene·2011
Same author

Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma.

British journal of cancer·2011
Same author

Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.

Oncogene·2007
Same author

Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha family.

Clinical pharmacology and therapeutics·2007
Same journal

Mechanisms of virus replication, persistence, and regulation of immune responses.

Clinical immunology and immunopathology·2020
Same journal

Cumulative subject index for volumes 86-89

Clinical immunology and immunopathology·1998
Same journal

D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.

Clinical immunology and immunopathology·1998
Same journal

Characterization of gastric Na+/I- symporter of the rat.

Clinical immunology and immunopathology·1998
Same journal

CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.

Clinical immunology and immunopathology·1998
Same journal

Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.

Clinical immunology and immunopathology·1998
See all related articles

Interferons are induced proteins that modulate cell function and immune responses. They show therapeutic promise for treating malignant and viral diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Interferons are crucial for host defense, acting as broad modulators of cellular functions.
  • Unlike continuously produced hormones like glucocorticoids, interferons are induced proteins.
  • Interferons are recognized for their therapeutic applications in oncology and virology.

Purpose of the Study:

  • To elucidate the mechanisms underlying the antitumor effects of interferons.
  • To highlight the established therapeutic utility of interferons in treating diseases.

Main Methods:

  • Review of existing literature on interferon function and therapeutic applications.
  • Analysis of proposed mechanisms for interferon-mediated antitumor activity.

Related Experiment Videos

Main Results:

  • Interferons exert antitumor effects through direct action on tumor cells or indirect modulation of immune responses.
  • Established therapeutic efficacy of interferons in managing malignant and viral conditions.

Conclusions:

  • Interferons are versatile immune modulators with significant therapeutic potential.
  • Further research into interferon mechanisms may enhance their clinical application for cancer and viral infections.